Impact of n-3 Fatty Acid Supplementation on the Metabolic Abnormalities in Children With NAFLD

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02201160

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:39.338933+00:00

Published At

2014-07-25T00:00:00+00:00

Record Updated At

2014-07-25

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Non Alcoholic Fatty Liver Disease (NAFLD)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2014-07-25"

protocolSection.identificationModule.nctId

"NCT02201160"

protocolSection.identificationModule.officialTitle

"Impact of n-3 Fatty Acid Supplementation on the Metabolic Abnormalities in Children With NAFLD"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Non Alcoholic Fatty Liver Disease (NAFLD) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.